TY - JOUR
T1 - Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine
AU - Egashira, T.
AU - Takayama, F.
AU - Yamanaka, Y.
AU - Takada, K.
AU - Takeda, H.
AU - Matsumiya, T.
PY - 2000
Y1 - 2000
N2 - When 30 mg/kg, p.o. of fluvoxamine, a selective serotonin reuptake inhibitor, was administered, significant increases of 3-methoxy-4-hydroxyphenylglycol (MHPG) and 5-hydroxy indole-3-acetic acid (5-HIAA) contents in rat cerebrospinal fluid (CSF) were observed from two days after administration of fluvoxamine in both the light and dark periods and in the dark period of the light/dark cycle, respectively. In long-term treatment with 15 mg/kg, p.o. of fluvoxamine, the level of MHPG in CSF exhibited no difference, whereas the levels of 5-HIAA showed a significant increase during the light periods. These results suggest that fluvoxamine enhances the 5-HT system, but only with long-term treatment.
AB - When 30 mg/kg, p.o. of fluvoxamine, a selective serotonin reuptake inhibitor, was administered, significant increases of 3-methoxy-4-hydroxyphenylglycol (MHPG) and 5-hydroxy indole-3-acetic acid (5-HIAA) contents in rat cerebrospinal fluid (CSF) were observed from two days after administration of fluvoxamine in both the light and dark periods and in the dark period of the light/dark cycle, respectively. In long-term treatment with 15 mg/kg, p.o. of fluvoxamine, the level of MHPG in CSF exhibited no difference, whereas the levels of 5-HIAA showed a significant increase during the light periods. These results suggest that fluvoxamine enhances the 5-HT system, but only with long-term treatment.
KW - Cerebrospinal fluid
KW - Monoamine metabolite
KW - Selective serotonin reuptake inhibitor
UR - http://www.scopus.com/inward/record.url?scp=0033817631&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033817631&partnerID=8YFLogxK
U2 - 10.1254/jjp.83.344
DO - 10.1254/jjp.83.344
M3 - Article
C2 - 11001181
AN - SCOPUS:0033817631
SN - 0021-5198
VL - 83
SP - 344
EP - 347
JO - Japanese Journal of Pharmacology
JF - Japanese Journal of Pharmacology
IS - 4
ER -